Home > Insider Trading > Filing (0001209191-14-064327)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1368078	L Michael Babich	444 South Ellis Street Chandler AZ 85224	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-21	20,000	$3.54	189,795	No	4	M	Direct
Common Stock	Disposition	2014-10-21	20,000	$40.17	169,795	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-10-21	20,000	$0.00	20,000	$3.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
243,750		2022-12-26	No	4	D	Direct

Footnotes

Includes 4,233 shares acquired by the Reporting Person on June 10, 2014 pursuant to the Issuer's ESPP.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The weighted average sales price for the transaction reported was $40.1702, and the range of prices were between $40.00 to $40.45.
The option vests in 36 equal monthly installments measured from the grant date of December 27, 2012 and will be fully vested and exercisable on December 27, 2015.